
Athletic apparel company Under Armour (NYSE: UAA) will be announcing earnings results this Friday before market hours. Here’s what investors should know.
Under Armour beat analysts’ revenue expectations by 1.9% last quarter, reporting revenues of $1.33 billion, down 4.7% year on year. It was a strong quarter for the company, with a beat of analysts’ EPS estimates and a solid beat of analysts’ adjusted operating income estimates.
Is Under Armour a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, analysts are expecting Under Armour’s revenue to decline 6.3% year on year to $1.31 billion, in line with the 5.7% decrease it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.01 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Under Armour has missed Wall Street’s revenue estimates twice over the last two years.
Looking at Under Armour’s peers in the apparel and accessories segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Columbia Sportswear’s revenues decreased 2.4% year on year, beating analysts’ expectations by 3.6%, and VF Corp reported revenues up 4.4%, topping estimates by 2.5%. Columbia Sportswear traded up 14.4% following the results while VF Corp’s stock price was unchanged.
Read our full analysis of Columbia Sportswear’s results here and VF Corp’s results here.
Investors in the apparel and accessories segment have had fairly steady hands going into earnings, with share prices down 1.2% on average over the last month. Under Armour is up 15.8% during the same time and is heading into earnings with an average analyst price target of $6.27 (compared to the current share price of $6.59).
P.S. STOP buying the AI stocks everyone's talking about. The real money? It’s in the profitable pick nobody’s watching yet. We’ve identified an AI profit machine that’s flying under Wall Street’s radar—for now. We can’t keep this research public forever—grab your FREE copy before we pull it offline. GO HERE NOW.

